Chacruna Institute for Psychedelic Plant Medicines is a registered California 501(c)(3) non-profit organization (EIN 84-3076078). We are a community-oriented organization run by a small staff of experts and enthusiastic volunteers who work to bring education and cultural understanding about psychedelic plant medicines to a wider audience. We promote a bridge between the ceremonial use of sacred plants and psychedelic science and envisage a world where plant medicines and other psychedelics are preserved, protected, and valued as part of our cultural identity and integrated into our social, legal, and health care systems.
Help us to achieve our mission! From our beginnings in 2017, we have stood apart from other psychedelic education and advocacy organizations by pioneering initiatives that support and provide a platform for diverse voices, including women, queer people, people of color, Indigenous people, and the Global South. In efforts to address the lack of diverse representation in the expanding psychedelic landscape, we centered our mission around the empowerment of marginalized voices to foster cultural and political reflections on topics like race, gender, and sexuality in psychedelic science. We believe now more than ever, given the current social and political climate, our work is critical to the future of psychedelic healing for humanity.
Please become a member so that you are able to help Chacruna, yourself, and the world. Support of any amount helps this cause and allows us to provide psychedelic education to anyone who wants to access it.
In this article, Marcelo Leite outlines the major developments in psychedelic science and markets going into 2024 that are causing industry trepidation. The biggest news of January comes from MAPS and its business division, which has been rebranded as Lykos Therapeutics.
Introduction
On Sunday, June 23, I attended the first “Ayahuasca Symposium” in London, UK, on behalf of Chacruna, a partner to the event. The event,...
Psychedelic Science 2023 brought together 12,000 registrants in Denver, Colorado, four times as many people as the previous conference in 2017, crowning the movement to rehabilitate psychedelics for therapeutic use against depression and other disorders. Science unveils unsuspected mechanisms of brain reconfiguration and ends decades of research bans imposed by the war on drugs, but serious obstacles remain to be overcome.
Location: Remote with opportunities for travel to conferences/eventsReports to: Executive DirectorJob Type: Unpaid InternshipDuration: 3 to 6 monthsHours: 5-10 per week
WHO WE ARE:The Chacruna Institute for Psychedelic Plant Medicines,...
Read Bia Labate's opening remarks for Psychedelic Science 2023 conference in Denver, Colorado, June 2023. She urges businesses, researchers, and clinicians to take reciprocity and community care seriously.